Comment on “PSMA response evaluation in follow-up PSMA-PET/CT after stereotactic ablative body radiotherapy (SABR) for oligometastases in prostate cancer”
The recently published study by Zang et al. offers valuable insight into PSMA-PET/CTbased response assessment in patients with oligometastatic prostate cancer (PCa) undergoing stereotactic ablative body radiotherapy (SABR), demonstrating an impressive 5-year local control rate of 86 % and progressiv...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2025-11-01
|
| シリーズ: | Clinical and Translational Radiation Oncology |
| 主題: | |
| オンライン･アクセス: | http://www.sciencedirect.com/science/article/pii/S2405630825001235 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|